UnitedHealth to offer rebates to its Obamacare customers
NEW YORK, Jan 21 (Reuters) – UnitedHealth Group Inc. (UNH.N), opens new tab will provide rebates to its…
Thailand releases endangered leopard sharks in conservation push
MAITON ISLAND, Thailand, Jan 26 (Reuters) – After a brief countdown by conservationists, a young Indo-Pacific leopard shark…
Singapore expected to keep monetary policy unchanged as growth outperforms
Item 1 of 2 A view of the Monetary Authority of Singapore building in Singapore April 18, 2016.…
OMV CEO says strict rules on plastic recycling could stifle innovation
Item 1 of 2 OMV CEO Alfred Stern briefs journalists in Vienna, Austria September 22, 2025. REUTERS/Lisa Leutner…
DOJ withdraws demand for Los Angeles hospital to turn over transgender minors’ records
Jan 23 (Reuters) – The U.S. Department of Justice has agreed to withdraw a subpoena demand that Children’s…
California joins UN health network following US departure from WHO
Jan 23 (Reuters) – California said on Friday it will become the first U.S. state to join the…
US climber scales Taiwan’s tallest building Taipei 101 without ropes
‘Free solo’ ascent organised and shown live by NetflixHonnold completed climb in an hour and a halfTaipei 101…
Many patients may keep off lost pounds after stopping a GLP-1, US data suggests
Real-world data suggests weight loss durability post-GLP-1 drug discontinuationStudy suggests weight regain may be less common than clinical…
Renewables push China’s fossil‑fuelled power into first annual drop in 10 years
BEIJING, Jan 19 (Reuters) – China’s mostly coal-based thermal power generation fell in 2025 for the first time…
Trump housing plan to allow 401(k) money for down payments, adviser says
WASHINGTON, Jan 16 (Reuters) – The Trump administration plans to allow investors to use some of their retirement…
BGI Genomics, Roche roll out diagnostic tests for Alzheimer’s in China
SHANGHAI, Jan 14 (Reuters) – BGI Genomics (300676.SZ), opens new tab and Roche Diagnostics (ROG.S), opens new tab…
Exclusive: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
Reviews of Sanofi’s diabetes drug Tzield and Disc Medicine’s blood-disorder medicine bitopertin stalledTzield pushed back after adverse event…